卡尔雷蒂库林的干扰增强了CD8+T细胞介导的抗瘤免疫力
Kaiyang Tang1, Lijian Wu1, Yuanzhi Hu1
1School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology, Tsinghua University , Beijing, China.
The Journal of experimental medicine
|August 20, 2025
概括
通过非激活卡尔雷图林 (CALR) 和载复合体 (PLC) 组件,意外地提升了对瘤的 CD8+ T 细胞反应. 这一发现为提高癌症免疫疗法的有效性提供了一种新策略.
科学领域:
- 免疫学
- 癌症生物学
- 分子生物学
背景情况:
- 有效的癌症免疫疗法取决于瘤新抗原通过MHC- I向CD8+ T细胞呈现.
- 抗原呈现障碍是免疫逃避和抵抗检查点阻断疗法的主要机制.
研究的目的:
- 研究MHC-I抗原表现和CD8+T细胞激活的新调节剂.
- 确定在癌症免疫治疗中克服耐药性的新治疗点.
主要方法:
- 进行了体内CRISPR-Cas9查,以确定影响抗瘤免疫力的基因.
- 分析了calreticulin (CALR) 和负载复合体 (PLC) 部件失活对MHC- I表现和T细胞反应的影响.
- 使用小鼠和人类细胞系研究MHC-I谱的机械效应.
主要成果:
- CALR和其他PLC组件的无活化意外诱导了强大的CD8+T细胞介导的抗瘤免疫反应.
- 观察到的效果取决于古典MHC- I在瘤细胞上的表达.
- CALR的损失改变了MHC-I谱,促进了低 afinity 的呈现.
- 另一种PLC成分PDIA3的抑制也显示出抗瘤作用.
结论:
- 在调节抗瘤免疫力方面,CALR和PLC发挥了以前未知的作用.
- 向CALR/PLC途径是一个有前途的策略来增强癌症免疫疗法.
- 这种方法有可能克服免疫抵抗并改善癌症患者的治疗结果.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K


